Thyroid Hormones
  • Chemistry of thyroid hormones:
    • Active isomer -- levo (L-form) -- thyroxine, triiodothyronine, reversed iodothyronine (reverse T4) {dextro (D) form: about 4% of the activity of the L form

return to main menu

  • Pharmacokinetics:
    • T4 -- well absorbed from the ileum and duodenum following oral administration-- about 80% absorbed on average
    • Modification of absorption:
      • food
      • drugs (e.g., sucralfate, iron, aluminum-containing antacids)
    • T3 -- almost completely absorbed (95%) following oral administration
    •  T4 and T3 absorption may be impaired by myxedema with ileus (may require parenteral administration {IV}, as a result)
    • Factors that alter T4 and T3 clearance:
      • hyperthyroidism: increases
      • hypothyroidism: decreases
      • Drugs (hepatic microsomal enzymes inducers): Clearance is enhanced;Euthyroid state may be maintained because of thyroid hyperfunction.
        • phenobarbital
        • carbamazepine
        • phenytoin
        • rifampin
    • Increases in the number of TBG binding sites (due to pregnancy, estrogen use, oral contraceptive use)
      • more thyroid hormone is bound; elimination rate declines (only free hormone can be eliminated); normal hormone concentration would be eventually restored

return to main menu

  • Mechanism of Hormone Action:
    1. Unbound T4 and T3 diffuse into the cell (passive diffusion, possibly active transport)
    2. Inside cell:
      1. T4 T3 by 5'-deiodinase
      2. T3 cell nucleus where T3 binds to a specific T3 nuclear receptor
        • Receptor:
          • Two classes of receptors, TRa TRb :
            • multiple isoforms (as a result of alternative splicing)
          • homologous with the c-erb oncogene family
            • c-erb (cellular (c) homologues of the avian retroviral v-erb A proto-oncogene.)
              • c-erb -A-a (TRa )
              • c-erb -B-b (TRb )
              • TR genes encode for:
                1. T3 binding domain
                2. DNA-binding domain which attaches to regulatory DNA sequences in genes with T3 regulated transcription (growth hormone genes, prolactin genes, TSH genes)
              • Activation and modulation of transcription rates are mediated by thyroid response elements (TREs-- regulatory sequences)
              • T3 -TR combined with auxiliary thyroid receptor proteins (TRAPs) interact with TREs to, for example:
                • inhibit synthesis of TSH
            • c-erb oncogene family includes:
              1. steroid hormone receptors
              2. vitamin A and D receptors
        • Tissue to tissue variation in response may be due to different concentration of thyroid receptor forms space for (T3 exists in two molecular forms)

return to main menu

  • Thyroid hormones: metabolic actions
    • nuclear receptor activation increased RNA and protein synthesis: examples --
      • increased Na/K ATPase increased ATP turnover, increased oxygen consumption --calorigenic effect
Thyroid Hormone Effects*

Physiological system

Hyperthyroidism (thyrotoxicosis)

Hypothyroidism

skin --appendages

warm, moist skin; sweating; fine, thin hair; Plumber's nails; pretibial dermopathy (Graves' disease)

pale, cool, puffy skin; brittle hair and nails

Eyes, face

Upper lid retraction (wide stare); periorbital edema; exophthalmos, diplopia (Graves' disease)

Eyelid drooping; periorbital edema; puffy, nonpitting facies; large tongue

Cardiovascular

decreased peripheral resistance, increased cardiac output, stroke volume, heart rate, pulse pressure; congestive heart failure (high-output); increased contractility,. arrhythmogenic; angina

increased peripheral resistance, decreased cardiac output, stroke volume, heart rate, pulse pressure; congestive heart failure (low output); bradycardia (low voltage ECG with prolonged PR interval, flat T wave); pericardial effusion

Respiratory

dyspnea; reduced vital capacity

hypoventilation (CO2 retention) pleural effusions

Gastrointestinal

increased appetite; increased bowel movement frequency; hypoproteinemia

decreased appetite, decreased bowel movement frequency; ascites

CNS

Nervousness, hyperkinesia, variable emotional states

lethargy, neuropathy

Musculoskeletal

Weakness; fatigue; hypercalcemia, osteoporosis, increased deep tendon reflex

muscle fatigue, reduced deep tendon reflex, increased alkaline phosphatase, LDH, AST

Renal

Increased renal blood flow; increased GFR; mild polyuria

Decreased renal blood flow; decreased GFR; reduced water excretion

Hematopoietic

anemia (increased RBC turnover); increased erythropoiesis

anemia (decrease production rate, decreased iron absorption, decreased folate acid absorption, autoimmune pernicious anemia),decreased erythropoiesis

Reproductive

decreased fertility; menstrual irregularity; enhanced gonadal steroid metabolism

infertility;hypermenorrhea, decreased libido; impotence, decreased gonadal steroid metabolism

Metabolic

increased basal rate; negative nitrogen balance, hyperglycemia; increased free fatty acids, decreased cholesterol and triglycerides; increased hormone degradation; increased requirement for fat-and water-soluble vitamins; enhanced drug detoxification

decreased basal rate; delayed insulin degradation, with increased sensitivity; enhanced cholesterol and triglyceride levels; decreased hormone degradation; decreased requirements for fat-and water-soluble vitamins; decreased drug detoxification.

* Adapted from Table 38-4, Greenspan, F.S., and Dong, B. J.. Histamine, Thyroid and Antithyroid Drugs, in Basic and Clinical Pharmacology, (Katzung, B. G., ed) Appleton-Lange, 1998, p 625.
Greenspan, F.S., and Dong, B. J.. Histamine, Thyroid and Antithyroid Drugs, in Basic and Clinical Pharmacology, (Katzung, B. G., ed) Appleton-Lange, 1998, pp 619-633.
Wartofsky, L., Diseases of the Thyroid, In Harrison's Principles of Internal Medicine 14th edition, (Isselbacher, K.J., Braunwald, E., Wilson, J.D., Martin, J.B., Fauci, A.S. and Kasper, D.L., eds) McGraw-Hill, Inc (Health Professions Division), 1998, pp 2012-2034